Insulin degludec - PDFSEARCH.IO - Document Search Engine

Insulin degludec
Results: 14

#	Item
1	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRESIBA® safely and effectively. See full prescribing information for TRESIBA®. TRESIBA® (insulin degludec inject Add to Reading List Source URL: www.novo-pi.com - Date: 2016-12-20 16:52:45
2	INSULIN TRESIBA – STELLUNGNAHME DER SGED Das Insulin Degludec (Tresiba) ist ein langwirkendes Insulin, das in der Schweiz und in Europa zugelassen ist. Hingegen ist es derzeit auf dem amerikanischen Markt nicht registr Add to Reading List Source URL: sgedssed.ch Language: German - Date: 2015-10-08 11:33:08
3	This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap Add to Reading List Source URL: www.novonordisk.ca Language: English - Date: 2016-08-18 19:09:23 Diabetes Peptide hormones Recombinant proteins Eli Lilly and Company RTT Insulin aspart Insulin Diabetes management Diabetes mellitus type 1 Glycated hemoglobin Hyperglycemia Insulin degludec
4	Tresiba, INN-insulin degludec Add to Reading List Source URL: www.ema.europa.eu - Date: 2013-07-21 06:39:48
5	fact file 18 New Insulins Scientific and technical advances in recent years have driven the development of a number of human and analogue insulins with better clinical and pharmacological properties Dr Victoria Stokes, S Add to Reading List Source URL: www.diabetes.org.uk Language: English - Date: 2014-03-27 10:01:20 Diabetes Endocrine system Eli Lilly and Company Medicine Insulin therapy Insulin analog Insulin glargine Insulin degludec Insulin Biology Peptide hormones Recombinant proteins
6	Ryzodeg® (insulin degludec/insulin aspart) passed the review by the First Committee on Drugs of Pharmaceutical Affairs in Japan Bagsværd, Denmark, 3 December 2012 – Novo Nordisk today announced that Ryzodeg® (insuli Add to Reading List Source URL: hugin.info Language: English - Date: 2012-12-03 01:33:41 Endocrine system Medicine Eli Lilly and Company Diabetes Novo Nordisk Insulin analog Insulin aspart Insulin degludec Insulin Peptide hormones Recombinant proteins Biology
7	INSULINE TRESIBA – PRISE DE POSITION DE LA SSED L’insulin degludec (Tresiba) est une insuline de longue durée d’action autorisée en Suisse et en Europe. Elle n’est par contre actuellement pas enregistrée sur Add to Reading List Source URL: www.sgedssed.ch Language: French - Date: 2014-06-30 07:19:06
8	INSULIN TRESIBA – STELLUNGNAHME DER SGED Das Insulin Degludec (Tresiba) ist ein langwirkendes Insulin, das in der Schweiz und in Europa zugelassen ist. Hingegen ist es derzeit auf dem amerikanischen Markt nicht registr Add to Reading List Source URL: www.sgedssed.ch Language: German - Date: 2014-07-01 04:41:46
9	Introduction: Degludec and Degludec/Aspart Endocrinologic and Metabolic Drugs Advisory Committee Meeting November 8, 2012 Jean-Marc Guettier, MDCM Add to Reading List Source URL: www.fda.gov Language: English Medicine Peptide hormones Recombinant proteins Eli Lilly and Company Insulin therapy Insulin glargine Diabetes management Diabetes mellitus type 1 Insulin Diabetes Endocrine system Biology
10	Microsoft Word - DRAFT Questions EMDAC[removed]docx Add to Reading List Source URL: www.fda.gov Language: English Endocrine system Diabetes Medicine Hypoglycemia Insulin aspart Insulin degludec Novo Nordisk Insulin glargine Insulin Biology Peptide hormones Recombinant proteins